Navigation Links
China Medical Technologies Reports Second Quarter Financial Results
Date:11/20/2007

income taxes liabilities based on the final purchase price

allocation in connection with FISH acquisition upon completion of

independent valuation.

(2) In computing diluted GAAP and non-GAAP earnings per ADS for the three

months ended September 30, 2007, interest expense and amortization in

connection with convertible notes were added back to net income before

dividing by the diluted number of ADS because potential shares from

the conversion of convertible notes were included. For the three

months ended June 30, 2007, the total number of potential shares to be

converted pursuant to the conversion of convertible notes was not

included in the computation of diluted earnings per ADS because to do

so would have been anti-dilutive.

For more information, please contact:

China Medical Technologies, Inc.

Winnie Fan

Tel: +86-10-6530-8833

Email: IR@chinameditech.com


'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...
(Date:12/16/2009)... ultimate CHO cell culture supplement? InVitria has what scientists have ... media supplement that improves the growth and productivity of CHO ... Zap-CHO is an animal free, well defined and consistent recombinant ... ... CO (PRWEB) December 16, 2009 -- Scientists working with CHO ...
(Date:12/16/2009)... and Separations Society will hold its 23rd Annual Technical Conference & ... San Antonio, Texas. To further impact the separation society and reach ... to announce that the 2010 AFS Annual Technical Conference will be ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- The American ...
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... announced today that the Company will host an investor ... PM Eastern Time to present an,analysis of the data ... IT-R-006) for the treatment of nasolabial folds, or,wrinkles. On ... results from these two studies, which met all primary ...
... benefits of ACTEMRA for rheumatoid,arthritis -, NUTLEY, ... a,total of 15 abstracts involving its investigational rheumatoid ... presentation,at the 2008 American College of Rheumatology (ACR) ... in San Francisco. These,studies evaluate ACTEMRA, a novel ...
... Ventures for Global Health to Work with Industry ... BIO Ventures for Global,Health (BVGH) today announced ... (FDA) release of Draft Guidance for Industry on ... is designed to,encourage industry investment in the development ...
Other Biology Technology:Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 3ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 4FDA Issues Draft Guidance on Priority Review Vouchers 2
(Date:12/16/2009)... DC US Secretary of Energy Steven Chu announced ... for their outstanding contributions in research and development supporting ... six winners named today will receive a gold medal, ... honored at a ceremony in Washington, DC early next ... the national, economic and energy security of the United ...
(Date:12/16/2009)... get psyched up for contests, but when these rituals ... down before and during events, they could be causing ... for the symptoms of an injury, not the injury ... focuses on musculoskeletal health and sports medicine. "They may ... certain level, but pain occurs for a reason. It ...
(Date:12/16/2009)... Medicine researcher will lead the coordinating center for a ... field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., ... the National Heart, Lung and Blood Institute (NHLBI) to ... which will be called the NHLBI Progenitor Cell Biology ... $30 million grant over seven years. , ...
Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2NSAIDs: Take 'em early and often when competing? Think again 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 1Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 2Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 4Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 5Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 6Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 7Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 8Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 9Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 10Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 11Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 12Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 13ETC Biomedical Announces Chamber Sale in India 13344 1ETC Biomedical Announces Chamber Sale in India 13344 2ETC Biomedical Announces Chamber Sale in India 13344 3ETC Biomedical Announces Chamber Sale in India 13344 4OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 1OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 2OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 3
... at Washington University in St. Louis and Arizona State University have ... by making an even rarer form of chlorophyll, chlorophyll d. Chlorophyll ... to the naked eye. , ... with virtually no other plant or bacterium in the world for ...
... of the most important metabolic processes in our bodies, ... intermediates have been produced in multigram quantitieswith one exception, ... University of Leipzig have finally done it. As they ... combination of one biotechnological and one chemical step, starts ...
... with diabetes, cardiac problems, kidney disorders or high blood ... technology. The new "smart" holograms, which can detect ... much simpler, cheaper and more reliable, write Chris Lowe ... hologram is a recording of an optical interference pattern ...
Other Biology News:Bacterium sequenced makes rare form of chlorophyll 2Bacterium sequenced makes rare form of chlorophyll 3Kilogram quantities at last! 2'Smart' holograms help patients help themselves 2